Transgenic Rats as a Model for Alzheimer's Disease
Author Information
Author(s): Agca Cansu, Fritz Jason J, Walker Lary C, Levey Allan I, Chan Anthony WS, Lah James J, Agca Yuksel
Primary Institution: University of Missouri College of Veterinary Medicine
Hypothesis
The study aims to develop a transgenic rat model that expresses human β-amyloid precursor protein to better understand Alzheimer's disease.
Conclusion
The APP21 rat line expresses high levels of human APP and could be a useful model for Alzheimer's disease research.
Supporting Evidence
- The APP21 rat line expresses significantly more APP mRNA than wild-type rats.
- Serum levels of human amyloid-beta were measurable in APP21 animals.
- The study demonstrates the feasibility of generating stable transgenic rat models for Alzheimer's disease research.
Takeaway
Scientists created special rats that can help us learn more about Alzheimer's disease by studying how a specific protein behaves in their brains.
Methodology
Transgenic rats were created using lentiviral vector infection of zygotes, and their APP expression was analyzed through various techniques including ELISA and Northern blot.
Potential Biases
Potential bias in the interpretation of results due to the limited number of transgenic lines studied.
Limitations
The study primarily focuses on two transgenic lines and may not represent all aspects of Alzheimer's pathology.
Participant Demographics
Fischer 344 rats were used as the genetic background for the transgenic models.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website